Global Veterinary Pharmaceuticals Market By Product Type (Antimicrobials, Ectoparasiticides, Endoparacitides, Endectoparaciticides, Anti-inflammatory Drugs, Anti-Obesity Drugs, Behavioral Products, Biologic Drugs and Others), By Animal Type (Farm Animals (Livestock, Poultry, Swine, and Equine) Companion Animals (Feline, Canine, and Avian), and Aquaculture), By Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, and E-Commerce), and Geography

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Veterinary Pharmaceuticals Market size is valued at USD 31.36 billion in 2021 and is expected to reach USD 55.52 billion by 2028, at a CAGR of 7.74% during the forecast period 2022-2028. Veterinary drugs and allied services are used to treat and/or improve the performance and health of animals. These medications are used to treat injuries, illnesses, and diseases in animals. Veterinary medicine comprises vaccines, veterinary medicines such antibacterial drugs, and diagnostic kits for curing pathogens in animals. Furthermore, the medicine is mostly used for animal health care, surgery, and prevention. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global Veterinary Pharmaceuticals market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Veterinary Pharmaceuticals Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Global Veterinary Pharmaceuticals Market Summary

Study Period

2023-29

Base Year

2022

CAGR

7.74%

Largest Market

Asia Pacific

Fastest Growing Market

Europe
Veterinary Pharmaceuticals Market Dynamics

The medicinal feed additives segment is also expected to witness a significant growth rate over the forecast period owing to their increasing usage in maintaining animal health. Furthermore, the rising global population is increasing the demand for meat as well as dairy, which also drives the growth of the medicinal feed additives segment.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Veterinary Pharmaceuticals Market Segmentation

By Product Type
  • Antimicrobials
  • Ectoparasiticides
  • Endoparasites
  • Endectoparaciticides
  • Anti-inflammatory Drugs
  • Anti-Obesity Drugs
  • Behavioral Products
  • Biologic Drugs
  • Others
 
By Animal Type
  • Farm Animals
    • Livestock
    • Poultry
    • Swine
    • Equine
  • Companion Animals
    • Feline
    • Canine
    • Avian
  • Aquaculture
 
Distribution Channel
  • Veterinary Pharmacies
  • Veterinary Hospitals
  • Veterinary Clinics
  • E-Commerce

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Research Methodology 1.1. Secondary and Primary research 1.1.1. Secondary Sources 1.1.2. Primary Sources 1.2. Market Revenue Estimation Methodology 1.3. Key Assumptions 1.4. Acronyms 2. Scope of Study 2.1. Market Definition 2.2. Objective of the Research 2.3. Regions covered in the study 3. Executive summary 4. Global Veterinary Pharmaceuticals Market Dynamic Factors 4.1. Drivers 4.1.1. Economic Drivers 4.1.2. Demand Side Drivers 4.1.3. Supply Side Drivers 4.2. Restraints 4.3. Opportunities/Unmet Needs of the Market 4.4. Trends 5. Unique Features of the Report 5.1. Competition analysis 5.1.1. Dash board of top players 5.1.2. Financial Analysis 5.1.3. Product & Services 5.1.4. Key Developments 5.1.5. Major Strategies 5.1.6. SWOT Analysis 5.2. Technological advancements in veterinary pharmaceuticals market 5.3. Recent investments in the industry 5.4. Regulatory landscape 5.4.1. U.S. 5.4.2. Europe 5.5. PESTLE analysis 5.6. Porter’s analysis 6. Global Veterinary Pharmaceuticals Market , By Product, 2015 - 2019 and Forecast, 2020 - 2026 6.1. Product Type 6.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 6.1.3. Antimicrobials 6.1.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 6.1.4. Ectoparasiticides 6.1.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 6.1.5. Endoparacitides 6.1.5.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 6.1.6. Endectoparaciticides 6.1.6.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 6.1.7. Anti-inflammatory Drugs 6.1.7.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 6.1.8. Anti-Obesity Drugs 6.1.8.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 6.1.9. Behavioral Products 6.1.9.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 6.1.10. Biologic Drugs 6.1.10.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 6.1.11. Others 6.1.11.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 7. Global Veterinary Pharmaceuticals Market Forecast, By Animal, 2015 - 2019 and Forecast, 2020 - 2026 7.1. Farm Animals 7.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 7.1.3. Livestock 7.1.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 7.1.4. Poultry 7.1.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 7.1.5. Swine 7.1.5.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 7.1.6. Equine 7.1.6.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 7.2. Companion Animal 7.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 7.2.3. Feline 7.2.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 7.2.4. Canine 7.2.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 7.2.5. Avian 7.2.5.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.2.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 7.3. Aqua Culture 7.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 8. 8. Global Veterinary Pharmaceuticals Market Forecast, By Route of administration, 2015 - 2019 and Forecast, 2020 - 2026 8.1. Oral 8.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 8.2. Parenteral 8.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 8.3. Topical 8.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 8.4. Others 8.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 9. Global Veterinary Pharmaceuticals Market Forecast, By Distribution Channel, 2015 - 2019 and Forecast, 2020 - 2026 9.1. Veterinary Pharmacies 9.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 9.2. Veterinary Clinics 9.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 9.3. Veterinary Hospitals 9.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 9.4. Others 9.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 10. Veterinary Pharmaceuticals Market Forecast, By Region Analysis, 2015 - 2019 and Forecast, 2020 - 2026 10.1. North America Veterinary Pharmaceuticals Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 10.1.1. Product Analysis 2015 - 2019 and Forecast, 2020 - 2026 by Revenue (USD Mn) and Y-o-Y Growth (%) 10.1.1.1. Product type 10.1.1.1.1. Antimicrobials 10.1.1.1.2. Ectoparasiticides 10.1.1.1.3. Endoparacitides 10.1.1.1.4. Endectoparaciticides 10.1.1.1.5. Anti-inflammatory Drugs 10.1.1.1.6. Anti-Obesity Drugs 10.1.1.1.7. Behavioral Products 10.1.1.1.8. Biologic Drugs 10.1.1.1.9. Others 10.1.2. Animal Type Analysis 2015 - 2019 and Forecast, 2020 - 2026 by Revenue (USD Mn) and Y-o-Y Growth (%) 10.1.2.1. Farm Animal 10.1.2.1.1. Livestock 10.1.2.1.2. Poultry 10.1.2.1.3. Swine 10.1.2.1.4. Equine 10.1.2.2. Companion Animal 10.1.2.2.1. Feline 10.1.2.2.2. Canine 10.1.2.2.3. Avian
  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Heska Co. (U.S)
  • Hester biosciences (India)
  • Merck & Co., Inc. (U.S)
  • Perrigo Company plc. (Ireland)
  • Vétoquinol S.A. (France)
  • Virbac S.A. (France)
  • Zoetis Inc. (U.S)